YOLFTbeta
60

Zhejiang Jiuzhou Pharm Co Ltd

603456 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

16.34CNY-0.76 (-4.44%)

Price History

Full chart

Market Stats

Previous Close17.10
Open17.00
Day Range16.29 – 17.01
52-Week Range12.00 – 22.25
Volume19.81M
Market Cap14.67B
P/E (TTM)25.00
Forward P/E0.00
EPS0.67
Dividend Yield1.19%
Beta0.03
50-Day Avg15.71
200-Day Avg15.90

About

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yi Jiang Mei
  • Employees4.79K
  • HeadquartersNo. 99 Waisha Road, Taizhou, China, 318000, China
  • Websitehttps://www.jiuzhoupharma.com

Leadership

  • Mr. Yi Jiang MeiPresident & Director · b. 1975
  • Mr. Yujie ShaVP, Financial Director & Director · b. 1980
  • Mr. Huilu LinVP, Secretary of the Board of Directors & Director · b. 1973
  • Dr. Yuanqiang LiVP & Director · b. 1967
  • Mr. Nonggang YangVice President · b. 1975
  • Ms. Minxia HuangVice President · b. 1976
  • Mr. Gong ChenVice President · b. 1982
  • An WuAccounting Supervisor

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue590.67M652.53M833.38M935.11M1.14B1.31B1.29B1.44B1.65B1.72B1.86B2.02B2.65B4.06B5.45B5.52B5.16B5.51B
Growth (%)-+10.47%+27.72%+12.21%+22.28%+14.53%-1.79%+12.31%+14.45%+3.89%+8.43%+8.30%+31.26%+53.48%+34.01%+1.44%-6.57%+6.74%
Cost of Revenue422.26M458.27M573.06M646.44M800.31M916.04M932.43M986.06M1.25B1.20B1.26B1.33B1.69B2.75B3.62B3.52B3.57B3.48B
Gross Profit168.41M194.26M260.32M288.67M343.11M393.54M353.78M458.45M404.44M517.27M606.21M690.43M956.47M1.32B1.82B2.00B1.59B2.03B
Gross Margin28.51%29.77%31.24%30.87%30.01%30.05%27.51%31.74%24.46%30.12%32.55%34.23%36.13%32.41%33.47%36.19%30.80%36.85%
Operating Expense119.33M112.81M136.51M160.70M174.58M193.26M229.57M241.69M287.82M341.63M412.47M404.99M500.32M563.20M714.36M823.29M857.47M796.76M
Operating Income49.08M81.45M123.81M127.96M168.54M200.28M124.21M216.76M116.62M175.64M193.74M285.44M456.15M753.64M1.11B1.18B732.19M1.23B
Operating Margin8.31%12.48%14.86%13.68%14.74%15.29%9.66%15.01%7.05%10.23%10.40%14.15%17.23%18.55%20.35%21.29%14.19%22.39%
EBITDA71.00M92.09M135.30M177.98M180.20M259.09M222.56M292.52M254.86M354.55M389.31M481.71M718.90M1.02B1.37B1.48B1.11B1.35B
EBITDA Margin12.02%14.11%16.24%19.03%15.76%19.78%17.30%20.25%15.42%20.64%20.91%23.88%27.16%25.04%25.13%26.77%21.50%24.53%
Net Income41.42M67.21M109.86M117.05M136.26M166.24M133.28M200.08M111.48M147.61M157.15M237.79M380.58M633.90M921.17M1.03B606.10M730.07M
Net Income Margin7.01%10.30%13.18%12.52%11.92%12.69%10.36%13.85%6.74%8.59%8.44%11.79%14.38%15.60%16.92%18.71%11.74%13.25%
R&D---42.65M57.39M60.31M54.48M76.80M76.39M85.25M87.15M94.50M114.23M173.36M287.38M330.83M314.91M256.99M
R&D as % of Total Revenue---4.56%5.02%4.61%4.24%5.32%4.62%4.96%4.68%4.69%4.31%4.27%5.28%5.99%6.10%4.67%
Interest Expense23.30M11.79M12.10M14.37M17.46M19.33M20.40M14.87M8.49M2.14M5.34M11.17M44.55M26.51M24.06M25.21M20.73M10.12M
Interest Expense % of Total Revenue3.94%1.81%1.45%1.54%1.53%1.48%1.59%1.03%0.51%0.12%0.29%0.55%1.68%0.65%0.44%0.46%0.40%0.18%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets586.69M634.32M855.97M1.11B1.34B1.55B2.21B3.34B3.00B3.14B3.30B4.67B5.00B7.04B7.91B10.85B11.13B10.60B
Total Liabilities411.27M388.45M512.03M653.04M746.26M814.26M624.98M819.46M432.01M461.77M526.81M1.81B1.92B2.46B2.54B2.32B2.52B1.81B
Total Equity172.18M242.09M339.47M456.76M592.59M732.60M1.58B2.52B2.56B2.68B2.77B2.85B3.08B4.58B5.30B8.46B8.54B8.72B
Cash92.93M89.83M81.86M94.61M97.76M117.65M213.85M226.12M258.60M403.77M276.11M565.15M324.57M1.12B1.10B3.21B2.75B1.54B
Total Debt246.50M199.79M262.55M366.68M406.57M427.87M120.59M265.00M12.90M29.72M32.00M871.84M938.22M704.58M351.44M400.94M202.28M-
Net Debt153.57M109.96M180.69M272.08M308.81M310.21M-93.26M38.88M-245.70M-374.05M-244.11M306.69M613.65M-416.23M-743.98M-2.48B-2.55B-

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow82.84M122.03M105.30M111.01M154.28M203.86M10.17M140.53M136.65M244.20M264.78M554.16M400.39M677.52M1.23B1.36B991.66M1.82B
Investing Cash Flow-29.91M-42.16M-154.68M-196.15M-156.69M-134.67M-307.33M-651.31M301.05M-132.21M-280.19M-661.72M-210.53M-765.44M-738.42M-1.06B-881.33M-
Financing Cash Flow-30.59M-89.11M46.51M83.31M12.33M-34.78M356.46M481.61M-360.79M-17.55M-63.52M111.22M-116.12M582.43M-608.96M2.10B-609.61M-
Capital Expenditure39.97M41.56M154.55M201.63M159.40M121.75M257.13M300.20M145.46M163.89M230.66M320.45M315.73M579.88M713.79M929.44M888.96M660.09M
Free Cash Flow42.87M80.47M-49.25M-90.62M-5.12M82.11M-246.96M-159.68M-8.81M80.31M34.12M233.71M84.67M97.64M511.99M430.88M102.69M1.16B
Dividends Paid20.56M22.76M24.33M19.84M27.45M55.10M66.66M54.75M73.37M45.53M93.55M161.18M160.66M166.28M208.58M358.65M471.30M450.41M
FCF to OCF51.75%65.94%-46.77%-81.64%-3.32%40.28%-2428.91%-113.63%-6.45%32.89%12.89%42.17%21.15%14.41%41.77%31.67%10.36%63.82%
Dividend Paid to FCF47.96%28.28%-49.40%-21.90%-535.95%67.10%-26.99%-34.29%-832.32%56.69%274.17%68.96%189.76%170.30%40.74%83.24%458.95%38.69%

Earnings

Report DateDec 31, 2014Apr 30, 2015Jul 31, 2015Oct 28, 2015Dec 31, 2015Apr 8, 2016Aug 26, 2016Oct 26, 2016Dec 31, 2016Apr 26, 2017Aug 15, 2017Oct 25, 2017Feb 13, 2018Apr 25, 2018Aug 20, 2018Oct 25, 2018Mar 11, 2019Apr 22, 2019Aug 19, 2019Oct 24, 2019Dec 31, 2019Apr 29, 2020Aug 25, 2020Oct 21, 2020Dec 31, 2020Apr 28, 2021Aug 16, 2021Oct 28, 2021Apr 19, 2022Aug 4, 2022Oct 25, 2022Apr 27, 2023Aug 14, 2023Oct 24, 2024Apr 14, 2025Aug 5, 2025Sep 30, 2025Dec 31, 2025Apr 23, 2026Aug 3, 2026
EPS Estimate---------------------------------0.190.190.220.280.260.320.29
EPS Actual0.030.050.100.080.040.050.000.060.030.050.040.050.040.060.050.010.080.050.070.040.130.130.120.140.180.110.220.240.190.310.330.210.380.170.280.310.25-0.020.190.25
Surprise----------------------------------10.53%47.37%40.91%-10.71%-107.69%-40.63%-13.79%
Timing-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hours--Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours--After-hoursAfter-hours

Key Statistics & Ratios

Market Cap14.67B
Enterprise Value13.12B
Trailing P/E25.00
Forward P/E0.00
Price / Sales2.81
Price / Book1.65
EPS0.67
Book Value10.20
Revenue (TTM)5.21B
Gross Profit (TTM)1.75B
EBITDA1.34B
Profit Margin11.35%
Operating Margin19.38%
Return on Equity6.57%
Return on Assets5.35%
Shares Outstanding875.54M
Shares Float477.13M
Beta0.03
Dividend Yield1.19%
Dividend Rate0.20
Payout Ratio44.78%

Dividends

20231×
0.40Jul 11, 2023
20221×
0.25Jul 13, 2022
20211×
0.20Jul 12, 2021
20201×
0.20Jul 8, 2020
20191×
0.20May 15, 2019
20181×
0.20Apr 12, 2018
20171×
0.06Jun 9, 2017
20161×
0.17May 26, 2016
20151×
0.06May 28, 2015

Stock Splits

  • Apr 12, 2018195077:108376
  • May 26, 20162:1